D27Subgroup analysis of patients with metastatic colorectal...

Annals of Oncology 2016 / 09 Vol. 27; Iss. suppl_4

D27Subgroup analysis of patients with metastatic colorectal cancer (mCRC) treated with regorafenib (REG) in the phase 3b CONSIGN trial who had progression-free survival (PFS) >4 months (m)

Salvatore, L., Ciardiello, F., Cascinu, S., Sobrero, A., Banzi, C., Barone, C., Gelsomino, F., Maiello, E., Siena, S., Bergamo, F., Cartenì, G., Di Costanzo, F., Di Bartolomeo, M., Rimassa, L., Russo,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw335.27
Date:
September, 2016
File:
PDF, 44 KB
2016
Conversion to is in progress
Conversion to is failed